The Discovery Health Diabetes Shared-Value Programme is designed to align with the goals of the patient, medical practitioner ...

Researchers have found in a new study that elevated triglyceride-glucose (TyG) index, a marker of insulin resistance, was ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

This program was supported through an independent medical education grant from Dexcom Medical Affairs. Experts discuss how continuous glucose monitoring (CGM) adoption impacts clinical inertia and ...

Kosuke Inoue, MD, PhD, from the Beth Israel Deaconess Medical Center in Boston, and colleagues examined trends in the prevalence and control of diabetes among US adults aged 20 years or older between ...

Pharmacist involvement in primary care chronic disease co-management of hypertension and T2D improved patients' blood ...

Between 2013 and 2023, there was no change in the prevalence of diabetes among U.S. adults, but glycemic control worsened, ...

No. 4 / 2025 Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with ...

The topic of diabetes will be the focus of the next Dinner with the Docs at 6 p.m. March 24 at the Grand Pointe Conference Center, 1500 Grand Central Ave., Vienna. “Connecting the Dots: the Impact of ...

The following is a summary of “Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in ...